Next Article in Journal
Repositioning Linagliptin for the Mitigation of Cadmium-Induced Testicular Dysfunction in Rats: Targeting HMGB1/TLR4/NLRP3 Axis and Autophagy
Next Article in Special Issue
New Horizons in Dermal and Transdermal Drug Delivery Systems
Previous Article in Journal
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
Previous Article in Special Issue
Assessing the Oxidative State of the Skin by Combining Classical Tape Stripping with ORAC Assay
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210

1
Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, 1649-003 Lisbon, Portugal
2
Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(7), 849; https://doi.org/10.3390/ph15070849
Submission received: 23 May 2022 / Accepted: 6 June 2022 / Published: 11 July 2022
(This article belongs to the Special Issue New Horizons in Dermal and Transdermal Drug Delivery Systems)
The authors would like to make the following corrections about the published paper [1]. The changes are as follows:
  • Missing Citation
In the original publication, refs. [2,3] was not cited. The citation has now been inserted in 4. The Skin Endocannabinoid System and the Use of Cannabinoids as a Potential Treatment for Skin Inflammatory Diseases, 4.1. The Skin Endocannabinoid System, Table 2 caption. Newly add references as [47,48] in the original paper, the order of some reference citation has been adjusted correspondingly.
“Table 2. The different classes of cannabinoids located in the skin, and some examples [15,37,47,48].”
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Martins, A.M.; Gomes, A.L.; Vilas Boas, I.; Marto, J.; Ribeiro, H.M. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. [Google Scholar] [CrossRef]
  2. Muller, C.; Morales, P.; Reggio, P.H. Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci. 2019, 11, 487. [Google Scholar] [CrossRef]
  3. Mnekin, L.; Ripoll, L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021, 8, 85. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Martins, A.M.; Gomes, A.L.; Boas, I.V.; Marto, J.; Ribeiro, H.M. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals 2022, 15, 849. https://doi.org/10.3390/ph15070849

AMA Style

Martins AM, Gomes AL, Boas IV, Marto J, Ribeiro HM. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals. 2022; 15(7):849. https://doi.org/10.3390/ph15070849

Chicago/Turabian Style

Martins, Ana M., Ana L. Gomes, Inês Vilas Boas, Joana Marto, and Helena M. Ribeiro. 2022. "Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210" Pharmaceuticals 15, no. 7: 849. https://doi.org/10.3390/ph15070849

APA Style

Martins, A. M., Gomes, A. L., Boas, I. V., Marto, J., & Ribeiro, H. M. (2022). Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals, 15(7), 849. https://doi.org/10.3390/ph15070849

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop